Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Wangen im Allgäu

5 clinical trials in Wangen im Allgäu, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Wangen im Allgäu at a glance
5
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Wangen im Allgäu

Open in trial search

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Obesity

Recruiting

Phase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Obesity+1

Recruiting

A study to evaluate the effectiveness and safety of eloralintide in adults with obesity or overweight without type 2 diabetes.

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:LY3841136 sodium
  • Sponsor:Eli Lilly & Co.

Study Comparing Trifluridine/Tipiracil with Panitumumab or Bevacizumab for Patients with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Study on the Effects of AZD5004 and Semaglutide for Adults with Type 2 Diabetes

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Other cities in Germany

The busiest research cities in the country

All 513 cities in Germany

Clinical research in Wangen im Allgäu

What the registry says about research in the country

01 Oncology

Clinical trial activity in Wangen im Allgäu includes research in neoplasms, with a focus on metastatic colorectal cancer. The studies are centered on comparing treatment approaches to find better options for people whose cancer has spread.

  • Metastatic colorectal cancer
  • Neoplasms
  • Comparing treatment effectiveness

This area reflects ongoing efforts to improve outcomes by testing new combinations and identifying more effective cancer care strategies.

02 Cardiovascular Disease

Research in cardiovascular diseases is examining people with type 2 diabetes, hypertension, and established cardiovascular disease. The main goal is to better prevent serious heart-related events and evaluate whether new treatment combinations can offer stronger protection.

  • Cardiovascular disease
  • Hypertension
  • Type 2 diabetes mellitus
  • Reducing heart failure and death risk

These trials focus on improving treatment effectiveness for patients with overlapping metabolic and heart conditions.

03 Nutritional and Metabolic Diseases

Clinical trials in the nutritional and metabolic diseases area are studying obesity, overweight, and type 2 diabetes mellitus. The research is aimed at assessing whether new therapies can improve blood sugar control and support meaningful weight reduction.

  • Obesity
  • Overweight
  • Type 2 diabetes mellitus
  • Improving glycemic control and body weight

These studies are especially relevant for people managing long-term metabolic health concerns.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.